BDTX BLACK DIAMOND THERAPEUTICS I
2026Q1 · CUSIP 09203E105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
98
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
54
Δ whales
+1
Inst. holding value
$77M
New positions
18
Closed positions
23
Price momentum (1Q)
—
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 2 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q2 | Top 8% | -32.5% | +64.3% |
| 2020Q1 | Top 1% | -26.8% | -19.1% |
Options Sentiment
Put holders
2
QoQ: -1
Call holders
3
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.75
EPS YoY
-1350.0%
Revenue (TTM)
$0.0B
Revenue YoY
-100.0%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)